
Illumina and Pacific Biosciences bring together highly accurate short- and long-read sequencing technologies. While Illumina short reads have enabled many sequencing projects, some applications (such as de novo sequencing) are best served by long reads. With its acquisition of PacBio, Illumina is positioned to provide integrated workflows that join the best of both technologies.
Customers can continue ordering Pacific Biosciences products, such as the Sequel II System and SMRT Sequencing kits, by contacting PacBio. In the future, you’ll be able to order both Illumina and PacBio products by placing an order online.
View Press ReleaseRead previous press releases from Pacific Biosciences. Future press releases from Illumina and PacBio can be found in the Illumina News Center.
The Sequel II System uses SMRT Sequencing to deliver highly accurate long reads.
SMRT Cells, Sequencing Kits, and accessories support automated SMRT Sequencing on Sequel Systems.
Explore peer-reviewed publications featuring PacBio long-read sequencing technology.